Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Progress in Cardiovascular Diseases, 89, 102112
In a Phase 2a substudy published in Nature Medicine, retatrutide at the 12mg dose reduced liver fat by an average of 82.4% from baseline at 24 weeks
Wegovy has also been approved by NICE for reducing cardiovascular risk in adults with obesity/overweight and established cardiovascular disease
Administration Instructions and Tips Inject Tresiba FlexTouch under the skin (subcutaneously) in upper arms, upper legs, abdomen, or buttocks, rotating injection sites to avoid skin issues
US$ 26.56
US$ 24.87
US$ 23.75
